Nu-Med Plus annual shares outstanding
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Nu-Med Plus Shares Outstanding History (NUMD)
Nu-Med Plus reported 83.5M shares outstanding at the end of fiscal 2025.
View full Nu-Med Plus company overviewNu-Med Plus annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 83.5M | 0 | 0.00% |
| 2024 | 2024-12-31 | 83.5M | 0 | 0.00% |
| 2023 | 2023-12-31 | 83.5M | 2.2M | +2.70% |
| 2022 | 2022-12-31 | 81.3M | 2.0M | +2.52% |
| 2021 | 2021-12-31 | 79.3M | 28.3M | +55.50% |
| 2020 | 2020-12-31 | 51.0M | 6.6M | +14.73% |
| 2019 | 2019-12-31 | 44.5M | 3.2M | +7.76% |
| 2018 | 2018-12-31 | 41.3M | 3.7M | +9.88% |
| 2017 | 2017-12-31 | 37.6M | 321,381 | +0.86% |
| 2016 | 2016-12-31 | 37.2M | 767,500 | +2.10% |
| 2015 | 2015-12-31 | 36.5M | 2.2M | +6.40% |
| 2014 | 2014-12-31 | 34.3M | 4.3M | +14.38% |
| 2013 | 2013-12-31 | 30.0M | 3.2M | +11.82% |
| 2012 | 2012-12-31 | 26.8M | 13.8M | +106.18% |
| 2011 | 2011-12-31 | 13.0M | — | — |
Nu-Med Plus quarterly shares outstanding
Q4.11
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q3.24
Q4.24
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 83.5M | 0 | 0.00% |
| Q1 2026 | 2026-03-31 | 83.5M | 0 | 0.00% |
| Q4 2025 | 2025-12-31 | 83.5M | 0 | 0.00% |
| Q4 2024 | 2024-12-31 | 83.5M | 2.2M | +2.70% |
| Q3 2024 | 2024-09-30 | 83.5M | 2.2M | +2.70% |
| Q1 2024 | 2024-03-31 | 83.5M | 2.2M | +2.70% |
| Q4 2023 | 2023-12-31 | 83.5M | 2.2M | +2.70% |
| Q3 2023 | 2023-09-30 | 81.3M | 2.0M | +2.52% |
| Q2 2023 | 2023-06-30 | 81.3M | 2.0M | +2.52% |
| Q1 2023 | 2023-03-31 | 81.3M | 2.0M | +2.52% |
| Q4 2022 | 2022-12-31 | 81.3M | 2.0M | +2.52% |
| Q1 2022 | 2022-03-31 | 79.3M | 0 | 0.00% |
| Q4 2021 | 2021-12-31 | 79.3M | 28.3M | +55.50% |
| Q3 2021 | 2021-09-30 | 79.3M | 29.1M | +57.98% |
| Q2 2021 | 2021-06-30 | 79.3M | 29.1M | +57.98% |
| Q1 2021 | 2021-03-31 | 79.3M | 34.9M | +78.40% |
| Q4 2020 | 2020-12-31 | 51.0M | 6.6M | +14.73% |
| Q3 2020 | 2020-09-30 | 50.2M | 8.7M | +20.99% |
| Q2 2020 | 2020-06-30 | 50.2M | 8.7M | +20.99% |
| Q1 2020 | 2020-03-31 | 44.5M | 3.0M | +7.14% |
| Q4 2019 | 2019-12-31 | 44.5M | 3.2M | +7.76% |
| Q3 2019 | 2019-09-30 | 41.5M | 580,000 | +1.42% |
| Q2 2019 | 2019-06-30 | 41.5M | 3.5M | +9.24% |
| Q1 2019 | 2019-03-31 | 41.5M | 4.0M | +10.52% |
| Q4 2018 | 2018-12-31 | 41.3M | 3.7M | +9.88% |
| Q3 2018 | 2018-09-30 | 40.9M | 3.2M | +8.46% |
| Q2 2018 | 2018-06-30 | 38.0M | 761,381 | +2.04% |
| Q1 2018 | 2018-03-31 | 37.6M | 321,381 | +0.86% |
| Q4 2017 | 2017-12-31 | 37.6M | 321,381 | +0.86% |
| Q3 2017 | 2017-09-30 | 37.7M | 500,525 | +1.34% |
| Q2 2017 | 2017-06-30 | 37.2M | −1.7M | −4.45% |
| Q1 2017 | 2017-03-31 | 37.2M | 767,500 | +2.10% |
| Q4 2016 | 2016-12-31 | 37.2M | 767,500 | +2.10% |
| Q3 2016 | 2016-09-30 | 37.2M | 1.1M | +3.07% |
| Q2 2016 | 2016-06-30 | 39.0M | 3.5M | +9.84% |
| Q1 2016 | 2016-03-31 | 36.5M | 2.2M | +6.40% |
| Q4 2015 | 2015-12-31 | 36.5M | 2.2M | +6.40% |
| Q3 2015 | 2015-09-30 | 36.1M | 2.9M | +8.56% |
| Q2 2015 | 2015-06-30 | 35.5M | 2.9M | +8.82% |
| Q1 2015 | 2015-03-31 | 34.3M | 2.2M | +7.01% |
| Q4 2014 | 2014-12-31 | 34.3M | 4.3M | +14.38% |
| Q3 2014 | 2014-09-30 | 33.3M | 3.5M | +11.67% |
| Q2 2014 | 2014-06-30 | 32.6M | 5.8M | +21.65% |
| Q1 2014 | 2014-03-31 | 32.0M | 5.2M | +19.51% |
| Q4 2013 | 2013-12-31 | 30.0M | 3.2M | +11.82% |
| Q3 2013 | 2013-09-30 | 29.8M | 16.8M | +129.26% |
| Q2 2013 | 2013-06-30 | 26.8M | — | — |
| Q1 2013 | 2013-03-31 | 26.8M | — | — |
| Q4 2012 | 2012-12-31 | 26.8M | — | — |
| Q4 2011 | 2011-12-31 | 13.0M | — | — |
Nu-Med Plus shares outstanding trends
Over the last five reported fiscal years, Nu-Med Plus's shares outstanding moved from 51.0M to 83.5M, a change of 32.5M. The latest reported quarter, Q2 2026, shows 83.5M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nu-Med Plus filings at SEC.gov ↗